Would like to think so Jason - but would urge caution as (if you...

Would like to think so Jason - but would urge caution as (if you check out other drug developers such as BNO or CXS) researchers present findings aside of the official phase trials. These dont normally need to be related to the "real" data, but support it. The biotech code of conduct would require a proper announcement before mentioning that some scientist was going to present a paper if that paper was to contain official data

PSD will rise steadily just not sure when, and dont know whether to top up one last time at current levels